In vitro effects of citrus oils against Mycobacterium tuberculosis and non-tuberculous Mycobacteria of clinical importance

Journal of Environmental Science and Health - Part B Pesticides, Food Contaminants, and Agricultural Wastes

Volumn 47, Issue 7, 2012, Pages 736-741

  Crandall, Philip G ^a   Ricke, Steven C ^a   O'Bryan, Corliss A ^a   Parrish, Nicole M ^b  

^a UNIVERSITY OF ARKANSAS   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

citrus; essential oils; Mycobacteria; Tuberculosis

Indexed keywords

ANTI-MYCOBACTERIAL; CITRUS; CITRUS OIL; CLINICAL ISOLATES; DRUG-RESISTANT STRAINS; GROWTH SYSTEMS; IN-VITRO; IN-VIVO; M. TUBERCULOSIS; MECHANISM OF ACTION; MYCOBACTERIA; MYCOBACTERIUM TUBERCULOSIS; ORANGE OIL; PARATUBERCULOSIS; TUBERCULOSIS; VALENCIA; VIABLE COUNT;

ECOLOGY; ESSENTIAL OILS;

TUBES (COMPONENTS);

ESSENTIAL OIL; VEGETABLE OIL;

ANOXIC CONDITIONS; ANTIBIOTIC RESISTANCE; BACTERIUM; ECOLOGICAL MODELING; ESSENTIAL OIL; EVERGREEN TREE; INFECTIOUS DISEASE; INHIBITION; TERPENE; TUBERCULOSIS; VEGETABLE OIL;

ARTICLE; CHEMISTRY; CITRUS; CLASSIFICATION; DRUG EFFECT; HUMAN; MICROBIOLOGY; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; TUBERCULOSIS;

CITRUS; HUMANS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; OILS, VOLATILE; PLANT OILS; TUBERCULOSIS;

BACILLI (CLASS); CITRUS; CITRUS SINENSIS; CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84861207418     PISSN: 03601234     EISSN: 15324109     Source Type: Journal    
DOI: 10.1080/03601234.2012.669331     Document Type: Article

References (25)

1. Earl, E. A., Altaf, M., Murikoli, R. V., Swift, S. and O'Toole, R. 2010. Native New Zealand plants with inhibitory activity towards Mycobacterium tuberculosis. BMC Comp. Altern. Med., 10: 25
2. WHO. 2009. Global tuberculosis control: surveillance, planning, financing: WHO report 2009 Available at http://whqlibdoc.who.int/publications/2009/9789241563802_eng.pdf (retrieved ccessed 27 April 2010)
3. CDC. 2003. Treatment of tuberculosis. MMWR, 52(RR11): 1-77.
4. Iseman, M. D. 1993. Treatment of multi-drug resistant tuberculosis. New Eng. J. Med., 329: 784-791.
5. Pillay, M. and Sturm, A. W. 2007. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin. Infect. Dis., 45: 1409-1414.
6. CDC. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR, 55: 301-305.
7. Holland, S. M. 2001. Nontuberculous mycobacteria. Am. J. Med. Sci., 321: 49-55.
8. O'Brien, R. J., Geiter, L. J. and Snider, Jr. 1987. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am. Rev. Respir. Dis., 135: 1007-1014., L.J.
9. De Groote, M. A. and Huitt, G. 2006. Infections due to rapidly growing mycobacteria. Clin. Inf. Dis., 42: 1756-1763.
10. Harris, N. B. and Barletta, R. G. 2001. Mycobacterium avium subsp. paratuberculosis in veterinary medicine. Clin. Microbiol. Rev., 14: 489-512.
11. Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W.H., Neefs, J-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., Williams, P., de Chaffoy, D., Huitric, E., Hoffner, S., Cambau, E., Truffot-Pernot, C., Lounis, N. and Jarlier, V. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science, 307: 223-227.
12. Tripathi, R. P., Tewari, N., Dwivedi, N. and Tiwari, V. K. 2005. Fighting tuberculosis: an old disease with new challenges. Medicinal Res. Rev., 25: 93-131.
13. Zhang, Y. and Amzel, L. M. 2002. Tuberculosis drug targets. Current Drug Targets, 3: 131-154.
14. Rojas, R., Caviedes, L., Aponte, J. C., Vaisberg, A. J., Lewis, W. H., Lamas, G., Sarasara, C., Gilman, R. H. and Hammond, G. B. 2006. Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera. J. Natural Prod., 69: 845-846.
15. Fisher, K. and Phillips, C. 2008. Potential antimicrobial uses of essential oils in food: is citrus the answer?. Trends Food Sci. Technol., 19: 156-164.
16. Hawkins, J. E., Wallace, R. J. Jr. and Brown, B. A. 1991. "Antibacterial susceptibility tests: Mycobacteria". In Manual of Clinical Microbiology, Edited by: Balows, A., Hausler, W. J. Jr., Herrmann, K. L., Isenberg, H. D. and Shadomy, H. J. 1138-1152. Washington, DC: ASM Press.
17. Siddiqi, S. H., Heifets, L. B., Cynamon, M. H., Hooper, N. M., Laszlo, A., Libonati, J. P., Lindholm-Levy, P. J. and Pearson, N. 1993. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J. Clin. Microbiol., 31: 2332-2338.
18. Parrish, N., Kuhajda, F., Heine, H., Bishai, W. R. and Dick, J. D. 1999. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis. J. Antimicrob. Chemother., 43: 219-26.
19. Wayne, L. and Hayes, L. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of non-replicating persistance. Infect. Immun., 64: 2062-2069.
20. Colston, M. and Lee, Y. 1985. Measurement of ATP generation and decay in Mycobacterium leprae in vitro. J. Gen. Microbiol., 131: 3331-7.
21. Parrish, N., Ko, C., Hughes, M., Townsend, C. A. and Dick, J. D. 2004. Effect of n-octanesulphonylacetamide (OSA) on ATP and protein expression in Mycobacterium bovis BCG. J. Antimicrob. Chemother, 54: 722-729.
22. Braddock, R. J. 1999. Handbook of citrus by-products and processing technology, 247New York: Wiley.
23. Camacho-Corona, M. D.R., Ramírez-Cabrera, M. A., González-Santiago, O., Garza-González, E., Palacios Ide, P. and Luna-Herrera, J. 2008. Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases. Phytother. Res., 22: 82-85.
24. Parrish, N. M., Ko, K. G. and Dick, J. D. 2009. Activity of DSA against anaerobically adapted Mycobacteriun bovis BCG in vitro. Tuberculosis, 89: 325-327.
25. Walsh, S. E., Maillard, J. Y., Russell, A. D., Catrenich, C. E., Charbonneau, D. L. and Bartolo, R. G. 2003. Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria. J. Appl. Microbiol., 94: 240-247.